Importantly, gene augmentation therapy also has great potential to treat other inherited disorders in the retina, such as autosomal dominant retinitis pigmentosa (adRP), which can be caused by mutations in over 25 known genes including RHO and RPE6538. The gene discussed is RHO; the disease is autosomal dominant retinitis pigmentosa.